Academic Journal
Q1European Journal of Medicinal Chemistry Reports
About European Journal of Medicinal Chemistry Reports
European Journal of Medicinal Chemistry Reports is a scholarly journal published by Elsevier Masson s.r.l.. SCImago 2025 lists it in Q1, with an SJR of 0.9 and H-index of 25.
Coverage: 2021-2026. Research categories: Chemistry (miscellaneous) (Q1); Molecular Medicine (Q2).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-04-27. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Synthesis and biological activity; Computational Drug Discovery Methods; Click Chemistry and Applications; Cholinesterase and Neurodegenerative Diseases; Synthesis and Biological Evaluation; Natural product bioactivities and synthesis.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Design, synthesis and antibacterial evaluation of amphiphilic 1,2,4-oxadiazole-based pyridinium salts
Sara Amata, Virginia Talarico, Gaspare Crisà, Giuseppe Pizzolanti et al.
2026-12 · DOI: 10.1016/j.ejmcr.2026.100365Small-molecule ferroptosis modulators in oncology: Design principles, evidence standards, and translational opportunities
Tania Ciaglia, Valeria Napolitano, Francesca Di Matteo, Alessia Bertamino et al.
2026-12 · DOI: 10.1016/j.ejmcr.2026.100366Synthesis, anti-cancer activity, Pim-3 inhibitory potency and zebrafish larvae toxicity evaluation of indolopyrazolocarbazole derivatives
Théo Frazier, Elisabeth Pereira, Reidun Aesoy, Andrea Trentani et al.
2026-12 · DOI: 10.1016/j.ejmcr.2026.100371Pyrazoline- and hydrazone-linked thiazole-triazole hybrids as potent dual-stage antileishmanial agents with antifolate activity
Esraa A. Abdelsalam, Wagdy M. Eldehna, Sherif F. Hammad, Nicolas Masurier et al.
2026-12 · DOI: 10.1016/j.ejmcr.2026.100369Therapeutic evaluation of thiadiazole–piperidinone hybrids as selective anticancer agents for advanced melanoma: Role of PI3K/AKT/mTOR inhibition and induction of cell cycle arrest, apoptosis, and autophagy
Kodisundaram Paulrasu, Hamida Hamida, Amarnath Marudamuthu, Shruthi Thada et al.
2026-12 · DOI: 10.1016/j.ejmcr.2026.100368Cinnamyl-driven GPR183 antagonists: Scaffold optimization toward non-opioid pain therapy
Israel I. Olayide, Elise Stuertz, Nick Latzo, Robert Devine et al.
2026-12 · DOI: 10.1016/j.ejmcr.2026.100373Coumarin-based phytochemicals decursin, osthole, and scoparone as new lead compounds for cerebrovascular protection in ischemic stroke
Mehdi Valipour
2026-12 · DOI: 10.1016/j.ejmcr.2026.100372Synthesis, structure, photophysical, photochemical, and biological properties of hybrid macrocyclic structures containing two naphthalene moieties and a tri(ethylene glycol) tether
Marco Paolino, Jacopo Venditti, Gabriele Manenti, Mario Saletti et al.
2026-12 · DOI: 10.1016/j.ejmcr.2026.100374Marine natural products for antifungal drug discovery: An updated review (2015–2025)
Salma A. Haggag, Ahmed K. ElHady, Nardine Adel, Mirna Y. Abouomar et al.
2026-12 · DOI: 10.1016/j.ejmcr.2026.100359Mangiferin from coffee leaves: Integrative insights into extraction, bioactivity, molecular mechanisms, pharmacokinetics, advanced delivery systems, food and nutraceutical potential
Eyasu Yohannis, Tilahun A. Teka, Yetenayet B. Tola, Tarekegn T. Unade et al.
2026-12 · DOI: 10.1016/j.ejmcr.2026.100367Small-molecule antibacterials and resistance-modifying agents
Nataliya Zelisko, Iryna Kovalenko, Danylo Lesyk, Andrii Vilenskyi et al.
2026-12 · DOI: 10.1016/j.ejmcr.2026.100364Preclinical validation of AMPDA-HB derivatives integrating Hsp70-specific TPP motif and anti-CD2 single domain antibody radiolabeled by Al18F approach for PET tumor imaging
Lisa Russelli, Jonathan Martinelli, Adriano Bolognani, Rachele Stefania et al.
2026-12 · DOI: 10.1016/j.ejmcr.2026.100375The multifunctional therapeutic potential of Dermaseptin S4 and its analogs: A comprehensive review of structure, mechanisms, and biomedical applications
Alireza Neshani, Mehdi Nabati Moghaddam, Mohammad Sadegh Damavandi
2026-12 · DOI: 10.1016/j.ejmcr.2026.100370Beyond arginine count: Rational engineering of amphipathic macrocyclic CPPs with enhanced intracellular delivery and endosomal escape
Duc Tai Nguyen, Michael Desgagné, Ulrike Froehlich, Andréanne Laniel et al.
2026-08 · DOI: 10.1016/j.ejmcr.2026.100358PROTACs in targeted protein degradation: Advances in development and AI-enhanced drug discovery
Mao Du, Tao Liu, Wenyu Wang, Shuai Fan et al.
2026-08 · DOI: 10.1016/j.ejmcr.2026.100332Discovery and optimization of small molecule inhibitors of the SLIT2/ROBO1 protein-protein interaction using DNA-encoded libraries
Nelson García-Vázquez, Shaoren Yuan, Moustafa T. Gabr
2026-08 · DOI: 10.1016/j.ejmcr.2026.100346Rational design of 3,4,5-trimethoxyphenyl-phenoxy-triazole derivatives as highly potent α-glucosidase inhibitors
Shahab Kermaninia, Morteza Farina, Mohammad Mahdavi, Aida iraji et al.
2026-08 · DOI: 10.1016/j.ejmcr.2026.100362Investigation on the antibacterial activity and molecular mechanism of rifamycin derivatives against methicillin-resistant Staphylococcus aureus
Feng Ye, Tengteng Che, Mingze Xu, Yanjiao Ding et al.
2026-08 · DOI: 10.1016/j.ejmcr.2026.100351Design and biological evaluation of imidazo[2,1-a]phthalazine compounds with antiproliferative properties in triple-negative breast cancer cells
Amanda Garrido, Pierre-Olivier Delaye, Lucie Brisson, Mélanie Pénichon et al.
2026-08 · DOI: 10.1016/j.ejmcr.2026.100333Recent advance in the targeted protein degradation technology for overcoming acute leukemia
Xin Jin, Zhonghua Shi, Zhuo Liang, Jia Chen et al.
2026-08 · DOI: 10.1016/j.ejmcr.2026.100331Reviews
Community Reviews
Version History
October 2, 2026 at 8:31 pm
October 2, 2026